Sign in

Hepatitis Monthly

Official Journal of Research Center for Gastroenterology and Liver Diseases

e-ISSN 1735-3408
p-ISSN 1735-143X
Authors GuideSubmit manuscript

Outline

The Efficacy of Lamivudine in Hepatitis B – related Cirrhosis

Authors

Seyed Moayed Alavian1,*, Ali Kabir1, Hamid Reza Torabi1
1Department of Gastroenterology, Baqiyatallah University of Medical Sciences, Tehran Hepatitis Center, Tehran, Tehran, IR.Iran
*Corresponding Author: Department of Gastroenterology, Baqiyatallah University of Medical Sciences, Tehran Hepatitis Center, Tehran, Tehran, IR.Iran Email: [email protected]
Hepatitis Monthly:Vol. 4, issue 8; e92943
Published online:Sep 30, 2004
Article type:Research Article
Received:May 05, 2019
Accepted:Sep 30, 2004
How to Cite:Alavian SM, Kabir A, Torabi HR. The Efficacy of Lamivudine in Hepatitis B – related Cirrhosis. Hepat Mon. 2004;4(8):e92943. doi:
KeywordsCirrhosisHepatitis BLamivudine

References

  • 1.
    The references are available in the PDF file.

Copyright

© 2004, Author(s). This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.

Similar Articles

30
Jun
2007

Efficacy of Lamivudine Therapy on Decompensated Liver Cirrhosis Due to Chronic Hepatitis B

Mahmood Yousefi Mashhour,
Fariborz Mansour Ghanaei,
Hosein Foroutan,
Hadi Ghofrani,
Zahra Purrasuli,
Farahnaz Joukar
PDF

Mashhour M, Ghanaei F, Foroutan H, Ghofrani H, Purrasuli Z, et al. Efficacy of Lamivudine Therapy on Decompensated Liver Cirrhosis Due to Chronic Hepatitis B. Hepat Mon. 2007;7(2):. doi:

17
Jun
2009

Lamivudine Resistance in Iranian Chronic Hepatitis B Patients

F Fallahian,
SM Alavian,
H Kayvani,
F Alaeddini,
F Zamani
PDF

Fallahian F, Alavian S, Kayvani H, Alaeddini F, Zamani F. Lamivudine Resistance in Iranian Chronic Hepatitis B Patients. Shiraz E-Med J. 2009;11(2):20359. doi:

1
Oct
2013

The incidence of Drug- Resistant Mutants in Patients With Chronic HBV Infection After Lamivudine Treatment

Sepide Ezzatpanah Fard,
Zohreh Sharifi,
Seyed Masoud Hosseini,
Mahmood Mahmoodian Shooshtari
PDF

Ezzatpanah Fard S, Sharifi Z, Hosseini SM, Mahmoodian Shooshtari M. The incidence of Drug- Resistant Mutants in Patients With Chronic HBV Infection After Lamivudine Treatment. Jundishapur J Microbiol. 2013;6(8):e7366. doi: https://doi.org/10.5812/jjm.7366

30
Jun
2009

Treatment of Hepatitis B Virus-Associated Acute Glomerulonephritis with Lamivudine: Case Report

Mojgan Jalalzadeh
PDF

Jalalzadeh M. Treatment of Hepatitis B Virus-Associated Acute Glomerulonephritis with Lamivudine: Case Report. Nephro-Urol Mon. 2009;1(1):. doi:

31
May
2011

The optimal threshold: Baseline serum hepatitis B virus DNA and alanine transaminase levels can predict the 2-Year on-treatment virological response to lamivudine

seyyed yasser saiedi hosseini
PDF

saiedi hosseini SY. The optimal threshold: Baseline serum hepatitis B virus DNA and alanine transaminase levels can predict the 2-Year on-treatment virological response to lamivudine. Hepat Mon. 2011;11(8):. doi: https://doi.org/10.5812/kowsar.1735143X.710

More by these authors

Seyed Moayed AlavianPubMedScholar
Ali KabirPubMedScholar
Hamid Reza TorabiPubMedScholar

Find related work

PubMed
Google Scholar
Create citation alert
Download PDF28.82 KB
Import into EndNoteImport into BibTex
Share
Cited by
Metrics
Comments
Number of Comments:0